The diagnosis and management of haematospermia

Gallagher, William; Ramsden, Alistair

doi:10.1002/tre.722

Cited by 1 publication

(1 citation statement)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…12,13 Additional sexual side effects of EBRT include altered sensation during orgasm, orgasmic dysfunction, ejaculatory dysfunction, incontinence during sexual activity, and changes to penile morphology and sensation. [14][15][16][17][18][19] The effect of SD on the quality of life (QoL) for men who have sex with men (MSM) is different as male-male sexual intercourse places a greater emphasis on erections, seminal fluid release, penis size, and the prostate as a pleasure centre, and also the change to an anal receptive role within a relationship may not be comfortable due to treatment, or desirable. 20,21 The evidence base relating to these issues suffers from variance in methods including ranges of scoring criteria, [22][23][24][25][26][27][28][29][30][31][32] and timing of both data collection and interventions.…”

Section: Introductionmentioning

confidence: 99%

Adequacy of sexual care information given to prostate cancer patients receiving radical external beam radiotherapy

Greenwood-Wilson

Bridge

2022

J Radiother Pract

View full text Add to dashboard Cite

Background: Despite the acknowledged value of providing prostate radiotherapy patients with sexual dysfunction (SD) information, there is little evidence related to patient perceptions of this or the extent to which information is provided to them. This study aimed to critically evaluate the quality and format of SD information given to patients before, during and after radical EBRT to treat prostate cancer. Method: Members of UK prostate cancer support groups were asked to complete an anonymous online survey tool seeking opinions of the SD information they were given before, during and after external beam radiotherapy (EBRT). Results: There were 56 responses to the survey with over 42% of respondents reporting that they had not received any SD information. Of those who did, 78·1% (25/32) received information before the start of EBRT. Physicians were the most involved in the provision of SD information, with nurses and therapeutic radiographers being underutilised. Responses were mostly negative, or neutral regarding the quality of SD information and the information received about impact on relationships, psychological and emotional health. Many participants wanted more information and support. Conclusion: This study demonstrates that prostate cancer patients who have undergone radical EBRT have not received adequate information relating to potential sexual function side effects and the psychological and emotional effects of SD. This information should be included in verbal and written information provided at all stages of the radiotherapy pathway.

show abstract